BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mendorf S, Witte OW, Grosskreutz J, Zipprich HM, Prell T. What Predicts Different Kinds of Nonadherent Behavior in Elderly People With Parkinson's Disease? Front Med (Lausanne) 2020;7:103. [PMID: 32269998 DOI: 10.3389/fmed.2020.00103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Prell T, Franke GH, Jagla-franke M, Schönenberg A. Identifying Patterns of Self-Reported Nonadherence Using Network Analysis in a Mixed German Cohort. PPA 2022;Volume 16:1153-62. [DOI: 10.2147/ppa.s362464] [Reference Citation Analysis]
2 Schönenberg A, Teschner U, Prell T. Expectations and behaviour of older adults with neurological disorders regarding general practitioner consultations: an observational study. BMC Geriatr 2021;21:512. [PMID: 34563125 DOI: 10.1186/s12877-021-02469-3] [Reference Citation Analysis]
3 Prell T, Siebecker F, Lorrain M, Tönges L, Warnecke T, Klucken J, Wellach I, Buhmann C, Wolz M, Lorenzl S, Herbst H, Eggers C, Mai T. Specialized Staff for the Care of People with Parkinson's Disease in Germany: An Overview. J Clin Med 2020;9:E2581. [PMID: 32784969 DOI: 10.3390/jcm9082581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zipprich HM, Mendorf S, Schönenberg A, Prell T. The impact of poor medication knowledge on health-related quality of life in people with Parkinson's disease: a mediation analysis. Qual Life Res 2021. [PMID: 34797508 DOI: 10.1007/s11136-021-03024-8] [Reference Citation Analysis]
5 Zipprich HM, Mendorf S, Lehmann T, Prell T. Self-Reported Nonadherence to Medication Is Not Associated with Health-Related Quality of Life in Parkinson's Disease. Brain Sci 2021;11:273. [PMID: 33671679 DOI: 10.3390/brainsci11020273] [Reference Citation Analysis]
6 Mendorf S, Witte OW, Zipprich H, Prell T. Association Between Nonmotor Symptoms and Nonadherence to Medication in Parkinson's Disease. Front Neurol 2020;11:551696. [PMID: 33192983 DOI: 10.3389/fneur.2020.551696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Castro GS, Aguilar-Alvarado CM, Zúñiga-Ramírez C, Sáenz-Farret M, Otero-Cerdeira E, Serrano-Dueñas M, González-Usigli HA, Bernal O, Leal-Ortega R, Estrada-Bellmann I, Meléndez-Flores JD, Miranda-Cabezas M, Martínez-Hernández HR, Giugni JC, Mejía-Rojas KK, Mori N, Raina GB, García Fernández CL, Pecci C, Álvarez-Villalobos NA, Micheli F. Adherence to treatment in Parkinson's disease: A multicenter exploratory study with patients from six Latin American countries. Parkinsonism Relat Disord 2021;93:1-7. [PMID: 34741998 DOI: 10.1016/j.parkreldis.2021.10.028] [Reference Citation Analysis]
8 Straka I, Minar M, Grofik M, Skorvanek M, Bolekova V, Gazova A, Kyselovic J, Valkovic P. Effect of Pillbox Organizers with Alarms on Adherence to Pharmacotherapy in Parkinson Disease Patients Taking Three and More Daily Doses of Dopaminergic Medications. JPM 2022;12:179. [DOI: 10.3390/jpm12020179] [Reference Citation Analysis]